Skip to content

Cognitive, Psychological, and Physical Functioning in Long-COVID Patients With Different Levels of Fatigue.

Cognitive, Psychological, and Physical Functioning in Long-COVID Patients With Different Levels of Fatigue.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05758558
Enrollment
69
Registered
2023-03-07
Start date
2023-05-05
Completion date
2024-06-01
Last updated
2026-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Acute COVID-19 Syndrome

Brief summary

Post COVID-19 usually occurs 3 months from the onset of COVID-19 with symptoms that last for at least 2 months and cannot be explained by an alternative diagnosis. Patients report a range of disabling symptoms such as fatigue, shortness of breath, cognitive impairment, memory loss and mental health and employment issues. This clinical heterogeneity complicates the identification of the appropriate needs and care. The aim of this cross-sectional study is to identify subgroups (clusters) of post COVID patients based on clinical symptoms, demographic characteristics, levels of fatigue and physical, cognitive and psychological functioning of the individuals.

Interventions

None listed

Sponsors

Hasselt University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

The participant must report current persisting symptoms (such as brain fog, anxiety, shortness of breath, headaches but also others) and indicate on the Post COVID-19 Functional Status Scale that these have an impact on everyday functioning (grade 2, 3, and 4). These symptoms need to be present for more than two months. Further inclusion criteria are: * Fatigue Severity Scale (FSS) score \> 4 * Aged over 18 years old * Willing to sign the digital informed consent * Dutch speaking and Dutch understanding * Be tested positive for COVID-19, i.e. by reverse transcription polymerase chain reaction (RT-PCR), computed tomography (CT) of the lungs, or symptom-based diagnosis by the general practitioner.

Exclusion criteria

* Pregnant women * Pacemaker, defibrillator * Brain or nerve disorders * Epilepsy * A copper spiral or recent bone fracture

Design outcomes

Primary

MeasureTime frameDescription
Physical evaluationDay 1Hand grip strength (Jamar hand dynamometer) \& Six Minute Walk Test (6MWT)
Fatigue severityDay 1Fatigue severity scale (FSS)
Psychological evaluationDay 1Anxiety and depression Scale (HADS); MINI-S, MINI International Neuropsychiatric Interview - Simplified (Overbeek \& Schruers 2019)
Cognitive evaluationDay 1Multi-modal Evaluation of Sensory Sensitivity (MESSY); Montreal Cognitive Assessment (MoCA)

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026